Our Services

Drug Regulatory

Comprehensive Saudi FDA (SFDA) regulatory support for pharmaceutical manufacturers and importers.

Overview

MCS provides regulatory consulting and compliance services to support pharmaceutical products entering and operating in the Saudi market. We assist manufacturers and importers in navigating Saudi Food and Drug Authority (SFDA) requirements with accuracy, efficiency, and regulatory confidence.

 

Our team works closely with both local and overseas pharmaceutical companies to streamline approvals, minimize regulatory risk, and ensure smooth market access in Saudi Arabia.

Our Role as Your Regulatory Partner

MCS acts as a trusted regulatory partner throughout the pharmaceutical product lifecycle — from initial classification and licensing to post-market compliance. We support clients by managing regulatory submissions, coordinating with relevant authorities, and ensuring continuous compliance with SFDA regulations.

 

Our focus is on providing clear guidance, structured processes, and proactive regulatory follow-up tailored to each product and business model.

Key Focus Areas

Who We Support

“Pharmaceutical compliance demands accuracy, consistency, and deep regulatory knowledge. At MCS, we support our clients with structured regulatory guidance and reliable follow-up to help them operate in the Saudi market with confidence.”

 

— CEO, MCS

Get Started Today

Let’s build something great together.

More services

Additional Regulatory Services

Medical Devices / Ivd

SFDA compliance and Authorized Representative services for medical and IVD manufacturers in Saudi Arabia.

Cosmetics

Regulatory support for cosmetic licensing, approvals, and market entry in Saudi Arabia.

Food

Compliance and regulatory assistance for food products entering the Saudi market.

Distributers Search

We connect you with trusted and qualified distributors across Saudi Arabia.

ISO Consultation

ISO certification and compliance support to improve efficiency and reduce risk.

Proceed Toward Your
Next Achievement

Many manufacturers face delays and risks not due to product quality — but because of regulatory complexity, unclear requirements, and inefficient compliance processes.